The cancers most frequently associated with elevated B12 include: Haematological malignancies: Acute and chronic myeloid leukaemia, polycythaemia vera, and certain lymphomas may increase B12 through abnormal production of B12-binding proteins or release from malignant cells Liver cancers: Hepatocellular carcinoma and metastatic liver disease can cause B12 release from damaged hepatocytes, as the liver stores a majority (approximately 50-60%) of the body's B12 reserves Solid tumours: Various solid organ cancers, particularly those with liver involvement, have been reported in association with elevated B12, though the mechanisms are less well understood The proposed mechanisms linking cancer to elevated B12 include increased production of haptocorrin (a B12-binding protein) by tumour cells, release of B12 from necrotic tumour tissue, and impaired cellular B12 uptake

Its completely unregulated and does not have FDA approval youre buying it from overseas compounding pharmacies or research chemical websites with zero quality control
The usual dose is 5-10ml, given IM two times per week
Heat degrades it
If you are searching for BPC 157 weight loss results, the honest answer is that reliable, human-tested evidence does not exist yet
Fat-loss and metabolic compound comparison Compound 5-Amino-1MQ Mechanism NNMT inhibitor